Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McGaw

Executive Summary

Announces 10-year licensing agreement with Nang Kuang Pharmaceutical Dec. 17. Nang Kuang, a Taiwan-based manufacturer of intravenous solutions and pharmaceuticals, will manufacture and market patented McGaw I.V. and enteral therapy products exclusively in Taiwan and non-exclusively in mainland China, Thailand, Pakistan, India, Indonesia, the Philippines, Vietnam, Malaysia, Singapore and Hong Kong. Under the agreement, McGaw will receive an immediate payment of $500,000 and royalties. Nang Kuang sales of McGaw products are forecast to exceed $130 mil. over the decade.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021971

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel